Pharmacotherapeutic issues associated with generic substitutions of antiseizure medications may not only be the result of the FDA’s bioequivalence standards.
Your search for evid returned 5 results
While depression is often cited as an adverse effect of β-blocker use, there is limited evidence supporting this causal relationship.
The study aimed to identify medication classes and specific SSRIs that provide high rates of remission as well as a low risk of adverse events when used in the treatment of panic disorder with or without agoraphobia.
This retrospective study aimed to determine the incidence of treatment deintensification in a real-world setting.
The retrospective review included 6 pediatric patients younger than 12 months of age in the neonatal intensive care unit.